Page last updated: 2024-10-18

dihydroxyphenylalanine and Brain Stem Neoplasms

dihydroxyphenylalanine has been researched along with Brain Stem Neoplasms in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Brain Stem Neoplasms: Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshimura, M1
Yamamoto, T1
Iso-o, N1
Imafuku, I1
Momose, T1
Shirouzu, I1
Kwak, S1
Kanazawa, I1

Other Studies

1 other study available for dihydroxyphenylalanine and Brain Stem Neoplasms

ArticleYear
Hemiparkinsonism associated with a mesencephalic tumor.
    Journal of the neurological sciences, 2002, May-15, Volume: 197, Issue:1-2

    Topics: Brain Stem Neoplasms; Carbon Radioisotopes; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents

2002